Xencor, Inc Increase (Decrease) in Deferred Income Taxes
Xencor, Inc (XNCR) reported Increase (Decrease) in Deferred Income Taxes of -$65.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2017-03-01
- Xencor, Inc increase (decrease) in deferred income taxes for the quarter ending 2016-12-31 was $335.00K.
- Xencor, Inc increase (decrease) in deferred income taxes for the quarter ending 2016-09-30 was $1.38M.
- Xencor, Inc increase (decrease) in deferred income taxes for fiscal 2016 was -$65.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|
| 2016-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.72M derived: sum of 2 quarters · filed 2017-03-01 | -$65.00K 10-K · filed 2017-03-01 | |
| 2016-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$400.00K 10-Q · filed 2016-11-02 | ||
| 2016-06-30 | -$1.78M 10-Q · filed 2016-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |